Smart Reporting Raises €23 Million in Series C

by Kay Aloha Villamor in April 23rd, 2024

Smart Reporting, a Munich, Germany-based company providing medical reporting technology, has raised €23 million in Series C funding. 


The round was led by TVM Capital Life Science, with participation from Bayern Kapital and existing investors. 

TVM is an international venture capital company that invests in innovations in the life science sector. TVM manages a total of around $900 million across several funds and is advised by an experienced transatlantic investment team. TVM's portfolio focuses on therapeutics and medical technologies from Europe and North America, emphasizing first-in-class or best-in-class assets with the potential to transform the standard of care for patients. 

Smart Reporting Use of Funds 

The company will use the funds to fuel product development and international partnerships to bolster its presence in the US, Canadian, Australian, and New Zealand markets. Additionally, the company has expanded its management team as part of its international growth strategy. 

About Smart Reporting 

Founded in 2014 by Wieland Sommer, Smart Reporting provides documentation software in the medical field. The company focuses on automating routine tasks while ensuring consistency by combining medical expertise with leading technology. Smart Reporting's medical documentation software is distributed worldwide by leading technology and device manufacturers. The company is headquartered in Munich and has set itself the goal of simplifying manual and repetitive processes in medical documentation while improving quality and data standardization. 

Funding Details 

Company: Smart Reporting GmbH 

Raised: €23.0M 

Round: Series C 

Funding Month: April 2024 

Lead Investors: TVM Capital Life Science  

Additional Investors: Bayern Kapital 

Company Website:  

Software Category: Medical Documentation 



Your cart